Biotech catalyst calendar

1869 upcoming events across 299 companies

Clinical trial readouts, FDA decision dates, SEC filings and earnings dates for publicly traded biotech and pharmaceutical companies, compiled from the ClinicalTrials.gov registry and SEC EDGAR. Every date links back to the filing or registry record it came from.

Dates marked est. are projected primary completion dates from the trial registry rather than company-confirmed announcement dates. A sponsor typically reports results some weeks after the completion date on record.

Next up

October 21, 2026 to October 31, 2026

DateTickerEventTypePhase
October 21, 2026 est. ALMS Next quarterly earnings (projected) Earnings —
October 21, 2026 est. ACRV Next quarterly earnings (projected) Earnings —
October 22, 2026 est. PRAX Next quarterly earnings (projected) Earnings —
October 22, 2026 est. KPTI Next quarterly earnings (projected) Earnings —
October 22, 2026 est. IVVD Next quarterly earnings (projected) Earnings —
October 22, 2026 est. QURE Next quarterly earnings (projected) Earnings —
October 22, 2026 est. GOSS Next quarterly earnings (projected) Earnings —
October 22, 2026 est. WST Next quarterly earnings (projected) Earnings —
October 22, 2026 est. ILMN Next quarterly earnings (projected) Earnings —
October 23, 2026 est. CLRB Next quarterly earnings (projected) Earnings —
October 23, 2026 est. KYTX Next quarterly earnings (projected) Earnings —
October 24, 2026 est. NBIX Next quarterly earnings (projected) Earnings —
October 25, 2026 est. RARE Next quarterly earnings (projected) Earnings —
October 26, 2026 est. TYRA Next quarterly earnings (projected) Earnings —
October 26, 2026 est. PGEN Next quarterly earnings (projected) Earnings —
October 27, 2026 est. INCY Next quarterly earnings (projected) Earnings —
October 27, 2026 est. CORT Next quarterly earnings (projected) Earnings —
October 28, 2026 est. EXEL Next quarterly earnings (projected) Earnings —
October 28, 2026 est. TEVA Next quarterly earnings (projected) Earnings —
October 28, 2026 est. BSX Next quarterly earnings (projected) Earnings —
October 28, 2026 est. CMPS Next quarterly earnings (projected) Earnings —
October 28, 2026 est. MPLT Next quarterly earnings (projected) Earnings —
October 29, 2026 est. BMY Next quarterly earnings (projected) Earnings —
October 29, 2026 est. AGIO Next quarterly earnings (projected) Earnings —
October 29, 2026 est. MDGL Next quarterly earnings (projected) Earnings —
October 29, 2026 est. BCYC Next quarterly earnings (projected) Earnings —
October 29, 2026 est. SGP Next quarterly earnings (projected) Earnings —
October 29, 2026 est. LXRX Next quarterly earnings (projected) Earnings —
October 30, 2026 JNJ A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies Trial Milestone Phase 1
October 30, 2026 est. TENX Next quarterly earnings (projected) Earnings —
October 30, 2026 MBX A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity Trial Milestone Phase 1
October 30, 2026 est. STOK Next quarterly earnings (projected) Earnings —
October 30, 2026 est. CNSY Next quarterly earnings (projected) Earnings —
October 30, 2026 ILMN 18F-mFBG Imaging for Myocardial Sympathetic Innervation Trial Milestone Phase 2
October 30, 2026 ILMN 18F-mFBG Cardiac Uptake With Lewy Body Dementia Trial Milestone Phase 2
October 31, 2026 AMGN Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104). Trial Milestone Phase 1
October 31, 2026 TAK A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer Trial Milestone Phase 1/Phase 2
October 31, 2026 ONC A Study to Investigate the Effect of the CYP3A Inducer Phenytoin and the CYP3A Inhibitor Itraconazole on the Pharmacokinetics of BGB-58067 in Healthy Participants Trial Milestone Phase 1
October 31, 2026 TGTX A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS) Trial Milestone Phase 3
October 31, 2026 TEVA A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations Trial Milestone Phase 3

Follow only the companies you care about. Pick your tickers and see their catalysts on one calendar, with cash runway alongside.

Open the tracker

Companies

AAPG · ABBV · ABEO · ABVX · ACAD · ACHV · ACIU · ACRV · ACTU · ADRX · AGEN · AGIO · AKBA · ALDX · ALKS · ALLO · ALMS · ALNY · ALT · ALXO · ALZN · AMGN · AMLX · AMRX · ANGO · ANNX · ANRO · ANVS · APLM · ARDX · ARGX · ARWR · ASND · ATNM · ATXI · AURA · AVBP · AVIR · AVLN · AWHL · AXSM · AZN · BCAX · BCLI · BCRX · BCTX · BCYC · BDTX · BEAM · BFRI · BIIB · BIOA · BLRX · BLTE · BMRN · BMY · BNTX · BRVE · BSX · BTMD · BYSI · CABA · CADL · CANF · CAPR · CATX · CELZ · CERS · CGEM · CGON · CLDX · CLLS · CLRB · CLYM · CMPS · CNSY · COAG · COGT · CORT · COYA · CRBP · CRDL · CRIS · CRMD · CRSP · CRVS · CYTK · DCTH · DFTX · DMAC · DNLI · DNTH · DRUG · DYN · EDIT · EIKN · ELDN · ENSC · ERAS · ETRA · EWTX · EXEL · EYPT · FATE · FDMT · FTH · GENB · GERN · GILD · GKOS · GNLX · GNPX · GOSS · GRCE · GRFS · GSK · HALO · HUMA · HURA · IBRX · IDYA · IKT · ILMN · IMCR · IMNM · IMNN · IMRX · IMTX · IMUX · IMVT · INBS · INCY · INSM · INTS · IONS · IOVA · IRD · IRON · IVVD · JAZZ · JNJ · KARD · KLRA · KNSA · KOD · KPRX · KPTI · KRYS · KURA · KYMR · KYNB · KYTX · LBRX · LKFT · LLY · LNTH · LONA · LPCN · LQDA · LRMR · LTRN · LXEO · LXRX · LYEL · MAIA · MANE · MAZE · MBRX · MBX · MCUJF · MDGL · MDWD · MESO · MGTX · MIRM · MLTX · MLYS · MNKD · MNOV · MPLT · MRK · MRNA · NBIX · NERV · NGEN · NGNE · NKTR · NKTX · NRIX · NTHI · NTLA · NUVB · NVCR · NVO · NVS · OCGN · OCS · OCUL · OGN · OKYO · OLMA · OMER · ONC · ONCY · ORIC · ORKA · ORMP · OTLC · OTLK · PBH · PBYI · PCRX · PCVX · PFE · PGEN · PHAR · PHAT · PHVS · PRAX · PROK · PRQR · PTCHF · PTGX · PVCT · PVLA · QNRX · QTTB · QURE · RADX · RAPP · RARE · RCUS · REGN · REPL · RGNX · RIGL · RLAY · RLMD · RNAC · RNXT · RVMD · RVPH · RXRX · RYTM · SGMT · SGP · SLDB · SLS · SMMT · SMNR · SNDX · SNY · SPRB · SRPT · SRRK · STOK · SUPN · SVA · SVRA · SXTP · SYRE · TAK · TARA · TCRX · TENX · TEVA · TGTX · TLSA · TMCI · TNGX · TPST · TRAW · TRDA · TRVI · TSHA · TTRX · TVTX · TYRA · URGN · UTHR · VALN · VCEL · VERA · VIR · VNDA · VOR · VRCA · VRTX · VSTM · VTGN · VTRS · VTVT · WST · WVE · XBIT · XENE · XFOR · XNCR · ZBIO

By month

September 2025 · October 2025 · November 2025 · December 2025 · January 2026 · February 2026 · March 2026 · April 2026 · May 2026 · June 2026 · July 2026 · August 2026 · September 2026 · October 2026 · November 2026 · December 2026 · January 2027 · February 2027 · March 2027 · April 2027 · May 2027 · June 2027 · July 2027 · August 2027 · September 2027 · October 2027 · November 2027 · December 2027 · January 2028 · February 2028 · March 2028 · April 2028

Macro

Trial results do not land in a vacuum. The US economic calendar carries CPI, jobs, GDP and FOMC dates alongside, since rates move biotech valuations as much as data does.

About this data

Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Nothing here is hand-entered. This is an information tool, not investment advice — verify anything you act on against the linked primary source.

Last updated 2026-10-20.